Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Adicionar filtros








Intervalo de ano
1.
Korean Journal of Nuclear Medicine ; : 371-373, 2017.
Artigo em Inglês | WPRIM | ID: wpr-786942

RESUMO

A 22-year-old woman was diagnosed with intermediate risk stage II Hodgkin lymphoma and treated with three cycles of adriamycin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by involved-field radiation therapy. A complete metabolic remission was achieved after two cycles of ABVD, which was maintained until three years after completion of treatment. Follow-up FDG-PET/CT four years after completion of treatment, however, showed a new FDG-avid (Deauville score of 4) lesion in the right scapula, suggesting relapsed disease. Computer tomography (CT)-guided biopsy of this lesion was performed and subsequent histological examination revealed a radiation-induced giant cell granuloma.


Assuntos
Feminino , Humanos , Adulto Jovem , Biópsia , Bleomicina , Dacarbazina , Doxorrubicina , Seguimentos , Células Gigantes , Granuloma de Células Gigantes , Doença de Hodgkin , Escápula , Vimblastina
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA